This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Sung Yoo Cho in Tumor Treatment
Introduction
Sung Yoo Cho is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has the potential to impact cancer therapies positively.
Latest Patents
Sung Yoo Cho holds a patent for "Pharmaceutical Combinations for Treating Tumor Comprising Anti-CD19 Antibody and Natural Killer Cell." This patent represents a crucial advancement in the development of targeted cancer treatments.
Career Highlights
Currently, Sung Yoo Cho is associated with Incyte Corporation, a leading biopharmaceutical company. His role at Incyte allows him to work on cutting-edge research and development in oncology.
Collaborations
Sung Yoo Cho collaborates with talented colleagues, including Su Hyun Gwon and Yu Kyeong Hwang. These partnerships enhance the innovative potential of his research and contribute to the advancement of cancer treatment.
Conclusion
Sung Yoo Cho's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to tumor treatment through his patent and collaborations highlight the importance of research in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile